Live Breaking News & Updates on Biotechnology services

Stay informed with the latest breaking news from Biotechnology services on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Biotechnology services and stay connected to the pulse of your community

CymaBay Therapeutics 4Q Loss/Shr 35c >CBAY

Please disregard the headline "Gilead Sciences Proposed to Acquire CymaBay for $32.50 Per Shr in Cash or a Total Equity Value of $4.3B," at 4:46 p.m. ET. The...

Gilead-sciences-proposed-to-acquire-cymabay , Sciences-proposed , Acquire-cymabay , Total-equity-value , Article-normal , Biotechnology-services , Pharmaceuticals , Healthcare-life-sciences , Biopharmaceuticals , Synd , Cymabay-therapeutics

Milestone Pharmaceuticals Shares Fall Premarket After Stock Offering

By Colin Kellaher Shares of Milestone Pharmaceuticals slid more than 20% in premarket trading after the biopharmaceutical company said it was raising $30...

Montreal , Quebec , Canada , Colin-kellaher , Milestone-pharmaceuticals , Article-normal , Biotechnology-services , Pharmaceuticals , Healthcare-life-sciences , Biopharmaceuticals , Financial-performance , Share-price-movement-disruptions

Madrigal Pharmaceuticals Replaces Chief Financial Officer

By Colin Kellaher Madrigal Pharmaceuticals has hired Mardi Dier to replace Alex Howarth as chief financial officer of the clinical-stage biopharmaceutical...

Alex-howarth , Colin-kellaher , Madrigal-pharmaceuticals , Mardi-dier , West-conshohocken , Article-normal , Biotechnology-services , Pharmaceuticals , Cancer-drugs , Healthcare-life-sciences , Biopharmaceuticals , Specialized-drugs-medications

Health Care Slips on Growth Doubts -- Health Care Roundup

Health-care companies slipped amid doubts about the outlook for growth. Lawyers for biopharmaceutical company Sorrento Therapeutics disputed allegations that...

Texas , United-states , Rob-curran , Novo-nordisk , Sorrento-therapeutics , Article-normal , Biotechnology-services , Pharmaceuticals , Healthcare-life-sciences , Biopharmaceuticals , Corporate-industrial-news , Political-general-news

Janux Shares Double After Positive Data From Ongoing Trials

By Stephen Nakrosis Shares of Janux Therapeutics doubled after hours Monday, following the release of data from ongoing dose escalation trials for...

Stephen-nakrosis , Janux-therapeutics , Article-normal , Biotechnology-services , Pharmaceuticals , Healthcare-life-sciences , Biopharmaceuticals , Biological-therapy , Healthcare-provision , Financial-performance , Share-price-movement-disruptions

Viking Therapeutics Stock Surges 100% on Positive Weight-Loss Drug Trial

Patients saw ‘significant’ reductions in body weight during a study of a weight-loss drug developed by Viking Therapeutics.

United-states , American , Eli-lilly , Karishma-vanjani , Novo-nordisk , Viking-therapeutics , Article-normal , Biotechnology-services , Pharmaceuticals , Machinery , Agricultural-machinery , Healthcare-life-sciences

Arcutis Biotherapeutics Shares Up on 4Q Narrowed Loss, Revenue Beat

By Adriano Marchese Arcutis Biotherapeutics shares were higher ahead of the morning trading bell Tuesday after the company reported better-than-expected...

Frank-watanabe , Arcutis-biotherapeutics , Adriano-marchese , Executive-frank-watanabe , Article-normal , Biotechnology-services , Pharmaceuticals , Healthcare-life-sciences , Biopharmaceuticals , Biological-therapy , Healthcare-provision

Pyxis Oncology Shares Up 21% in Premarket Trading on $50M Fundraise

By Adriano Marchese Pyxis Oncology shares were sharply higher ahead of the morning bell on Tuesday after the company said it will raised $50 million by way...

Boston , Massachusetts , United-states , Adriano-marchese , Article-normal , Biotechnology-services , Healthcare-life-sciences , Financial-performance , Share-price-movement-disruptions , Corporate-funding , Corporate-industrial-news

Minerva Neurosciences Shares Slide on Latest FDA Roluperidone Setback

By Colin Kellaher Minerva Neurosciences shares lost more than half of their value in early trading Tuesday after the U.S. Food and Drug Administration once...

Minerva-neurosciences , Colin-kellaher , Drug-administration , Article-normal , Biotechnology-services , Pharmaceuticals , Healthcare-life-sciences , Biopharmaceuticals , Regulation-government-policy , Financial-performance , Share-price-movement-disruptions , New-products-services

Amgen, Chevron share losses lead Dow's 110-point fall

Shares of Amgen and Chevron are trading lower Tuesday morning, dragging the Dow Jones Industrial Average into negative territory. Shares of Amgen and Chevron...

Chevron , Amgen , Dow-jones-industrial-average , Article-normal , Biotechnology-services , Pharmaceuticals , Healthcare-life-sciences , Biopharmaceuticals , Us-djia , Amgen-inc- , Us-amgn